Cronos Group reported its quarterly earnings that surpassed analysts’ expectations.
The cannabis research company’s earnings came in at $0.21 per share for the quarter, beating the Zacks' consensus estimate of $0.13. Earnings in the prior-year quarter were $0.19 a share.
Revenue rose +79.6% from the year-ago quarter to $20.40 million, compared to analysts' expectations of $23.03 million.
Cronos Group had a negative net margin of 258.59% and a negative return on equity of 9.48%.